Highlights in chronic myeloid leukemia from ASH 2024 include data on efficacy of asciminib over TKIs, benefit from the third-generation TKI olverembatinib, and importance of molecular monitoring.

Prexigebersen is under clinical development by Bio-Path and currently in Phase II for Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia). According to GlobalData, Phase II drugs for Acute ...

The allogeneic bone marrow-derived mesenchymal stromal cell (MSC) therapy Ryoncil (remestemcel-L-rknd) has been approved for ...

In an analysis Thursday, the agency said the mutations it identified in samples taken during the patient's hospitalization weren't found in the birds, suggesting they aren't in the virus widely ...

A surge in flu cases across Scotland has placed health services in the country under "acute pressure", Public Health Scotland (PHS) has warned. Data from PHS showed 1,163 people were hospitalised ...

Turkey is set to implement stringent crypto regulations by February 2025 as part of their effort to tighten anti-money laundering (AML) frameworks to align with global standards. This legislative move ...

Myelofibrosis may be diagnosed with a bone marrow biopsy. Chronic myeloid leukemia, chronic eosinophilic leukemia, and chronic neutrophilic leukemia can show abnormal numbers of specific white blood ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...